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ABSTRACT: Infective endocarditis (IE) is a complex disease with 
cardiac involvement and multiorgan complications. Its prognosis 
depends on prompt diagnosis that leads to an aggressive therapeutic 
management combining antibiotic therapy and early cardiac surgery 
when indicated. However, IE diagnosis always poses a challenge, 
and echocardiography remains diagnostically imperfect in cases of 
prosthetic valve IE or cardiac implantable electronic device infection. In 
recent years, other imaging modalities (computed tomography, magnetic 
resonance imaging, nuclear imaging) have experienced significant 
technical improvements, and their application to the detection of 
cardiac and extracardiac IE-related lesions seems to be a strategic 
way forward in the management of patients with suspected IE. 
However, the scientific evidence in the literature remains limited; 
current guidelines address the use of the multimodality imaging 
in the field of IE with caution; the incremental value of each 
technique and their combinations is debated; and their use varies 
across countries. Despite these limitations, healthcare providers 
and surgeons should be aware of the possibilities offered by 
the multimodal imaging approach when appropriate. Here, we 
emphasize the value of a multidisciplinary heart valve team, the 
endocarditis team, underlining the importance of cardiac and 
extracardiac imaging experts in playing a key role in informing the 
diagnosis and management of patients with IE. Illustrative cases, 
critical appraisal of contemporary data, and conceptual and practical 
suggestions for clinicians that may help to improve the prognosis of 
patients with IE are provided in this review article.
© 2019 American Heart Association, Inc.
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Infective endocarditis (IE) is a complex and deadly dis-ease that is associated with cardiac-localized infec-tion and multiorgan complications. Likewise, cardiac 
implantable electronic device (CIED) infection consti-
tutes a complex scenario. In some cases, it is superim-
posable to valve endocarditis (when there is intravascu-
lar infection), whereas in other cases, it differentiates 
substantially from the classic concept of endocarditis 
(when there is only infection of the generator or the 
extravascular segment of the device). Diagnosis of IE 
remains challenging and includes identification of the 
infective pathogen and detection of cardiac lesions and 
noncardiac localization of the disease. Evidence of valve 
or intracardiac material involvement is a major diagnos-
tic criterion, with echocardiography representing the 
first-line imaging method. However, it is well known 
that echocardiography has several limitations, and 
other imaging modalities (computed tomography [CT], 
magnetic resonance imaging, nuclear imaging) have 
progressively been shown to be useful to demonstrate 
or depict both valve involvement and the presence of 
IE-related peripheral complications (metastatic infection 
and infectious embolism), as well as occult predisposing 
lesions that may be the source of infection. Anatom-
ic imaging such as multislice CT or hybrid modalities, 
which combine both anatomic and metabolic informa-
tion such as positron emission tomography (PET)/CT 
and single photon emission tomography (SPECT), has 
been shown to be particularly useful in the presence of 
implantable/prosthetic material (valve prostheses, CIED, 
or other intracardiac implanted material).1,2 Therefore, 
these techniques have gradually been included in the 
global assessment of patients with suspected IE, and 
the 2015 European Society of Cardiology (ESC) guide-
lines encouraged the multimodality imaging (MMI) ap-
proach by introducing image findings as new IE crite-
ria.3 However, the indication for each imaging modality 
remains unclear, and their recommendations for use are 
not organized or not well stated, included, or integrat-
ed into diagnostic workup algorithms. Hence, despite 
robust evidence supporting the value of MMI, the use 
of these imaging techniques has not yet been standard-
ized and varies widely in clinical practice.4,5
The 2 main diagnostic challenges in patients with sus-
pected IE or CIED infection are the confirmation of local 
involvement at the cardiac/device level and the detec-
tion of distant lesions related to the infectious process. 
Each technique has its diagnostic pros and cons in terms 
of these 2 issues (Table). In this sense, clinical discussion 
within the endocarditis team is, in our experience, the 
best way to overcome the limitations of the imaging 
techniques, thus optimizing imaging results for subse-
quent patient management. This review summarizes the 
current knowledge of the MMI approach in IE with the 
intent of providing evidence-based recommendations for 
each imaging technique and practical algorithms for the 
integrated use of MMI in different IE clinical scenarios.
SCENARIO 1: LEFT-SIDED IE
Value and Limitations of 
Echocardiography
Echocardiography is the first-line imaging modality to 
be performed in the context of IE. Echocardiography is 
of major importance for the diagnosis of IE and the as-
sessment of disease severity, providing prognostic data 
such as embolic risk and patient follow-up assessments. 
The main echocardiographic criteria for IE are vegeta-
tions, perivalvular complications (abscess, pseudoaneu-
rysm, new dehiscence of prosthetic valve), intracardiac 
fistula, and valve perforation or aneurysm.3
Both transthoracic (TTE) and transesophageal (TEE) 
echocardiography should be performed.6 TEE allows 
better evaluation in several situations in which TTE has a 
limited sensitivity4 such as prosthetic valve IE (PVE)5 and 
small vegetations7 and in the presence of perivalvular 
abscess.8 Three-dimensional TEE allows better delinea-
tion of valvular vegetations and abscesses, perforations 
and paravalvular leaks, dehiscence, and localization of 
infection with regard to valve anatomy and its relation-
ship with surrounding cardiac structures.
Echocardiography is also useful in predicting embolic 
events. Among several factors that have been associ-
ated with an increased risk of embolism9 (age, diabetes 
mellitus, atrial fibrillation, embolism before antibiotics, 
vegetation size, and Staphylococcus aureus infection10), 
the size and mobility of vegetations are the most po-
tent predictors of embolic events in patients with IE.10–14 
For example, the risk of neurological complications is 
particularly high in patients with large vegetations (>30 
mm in the greatest dimension).15 The 2015 ESC guide-
lines recommend urgent surgical therapy in the case of 
a large vegetation (>10 mm) after ≥1 embolic episodes, 
especially when the large vegetation is associated with 
other predictors of a complicated course.3
Value and Limitations of Cardiac CT 
Angiography and Extracardiac CT
ECG-gated cardiac CT with angiography (CTA) or with-
out angiography is an imaging modality able to assess 
both valve and perivalvular IE lesions.16 The 2015 ESC IE 
guidelines criteria included consideration for the use of 
cardiac CT in cases of possible IE or IE not confirmed by 
other criteria with high clinical suspicion in both native 
valve IE (NVE) and PVE, with special emphasis on the 
detection of perivalvular complications.3
Compared with surgical findings in left-sided valve 
IE, the sensitivity and specificity of CT to detect perival-




 http://ahajournals.org by on January 13, 2021
Erba et al MMI in Endocarditis
STATE OF THE ART
Circulation. 2019;140:1753–1765. DOI: 10.1161/CIRCULATIONAHA.119.040228 November 19, 2019 1755
high (>95%),16 especially in the aortic position.17 Detec-
tion of valve lesions as vegetations, leaflet thickening, 
valve perforation, or valve aneurysm is also feasible.16 
An excellent correlation with operative findings has 
been reported, with 96% sensitivity and 97% specifici-
ty of CT compared with surgery in a per-valve analysis,17 




Pros Cons Pros Cons
Cardiac 
assessment
Echocardiography Good diagnostic ability in NVE
(vegetations, leaks)
Acceptable diagnostic ability in PVE
(TEE>TTE)
Valvular function assessment
Evaluation of the hemodynamic 
consequences of the valve damage 
and PHT
Prognostic value
Prediction of embolic risk
Useful for follow-up
Limited for evaluating 
anterior structures and 
RVOT tract (right-sided IE)








ability in CDIRE 
(TEE>TTE)
Tricuspid valve function 
and PHT assessment
Detection of potential 
residual material after 
device extraction
NA for generator /
pocket and extracardiac 
or extravascular lead 
infection
Frequent difficulties 







Cardiac CTA Good ability to detect perivalvular 
complications in both NVE and PVE 
(abscess/pseudoaneurysm)
Acceptable diagnostic ability for 
detecting vegetations, leaflet 
thickening and perforation, fistulas
Coronary artery preoperative 
assessment
Limited in small 
vegetations
Radiation exposure/risk of 
nephrotoxicity*
Detection of soft-tissue 
lesions and infected 
collections around the 
generator
Assessment of venous 
accesses permeability 
(relevant for 
implantation of a new 
device)
Limited diagnostic 
ability for CDRIE (small 












and specificity for 
generator/pocket 









High sensitivity in PVE
Hypermetabolism+anatomic lesions 
(vegetations, leaflet thickening and 
perforation, fistulas)
Detection or clarification of 
perivalvular/periprosthetic 
complications
Better definition of the locoregional 
extension of the infection
Evaluation of other prosthetic 
materials beyond prosthetic valves 
(eg, in patients with congenital heart 
disease)
Low sensitivity in NVE
Limited in small 
vegetations
Possible false-positive 
studies resulting from 
inflammation (not 
recommended until > 3 
mo after surgery) or FDG 
uptake of the
prosthetic materials
Possible false negative 




Radiation exposure/risk of 
nephrotoxicity*
Very high sensitivity 
and specificity for 
generator/pocket 
and extracardiac or 
extravascular lead 
infection
Evaluation of other 
prosthetic materials 
beyond cardiac 
device (eg, coexisting 
prosthetic valve)
Assessment of venous 
accesses permeability
Low sensitivity for 
CDRIE (small and mild 
hypermetabolism of 













Detection of distant lesions (embolic/
metastatic)
Alternative diagnosis in rejected IE
Detection of the infection source 
(especially in some IE-related 
microorganisms, sometimes 
unknown neoplastic lesions)
Detection of pulmonary 
embolic lesions




Detection of distant lesions and 
systemic complications: intra-
abdominal emboli, pulmonary 
embolic lesions, central nervous 
system, spondylodiscitis, mycotic 
arterial aneurysms
Radiation exposure/risk of 
nephrotoxicity*




CDRIE indicates cardiac device–related infective endocarditis; CIED, cardiac implantable electronic device; CTA, cardiac tomographic angiography; FDG, 
fluorodeoxyglucose; IE, infective endocarditis; MRI, magnetic resonance imaging; NA, not applicable; NVE, native valve endocarditis; PET, positron emission 
tomography; PHT, pulmonary hypertension; PVE, prosthetic valve endocarditis; RVOT, right ventricular outflow tract; TEE, transesophageal echocardiography, TTE, 
transthoracic echocardiography; and WBC-SPECT, white blood cell single-photon emission computed tomography.
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as well as excellent reported interobserver agreement.18 
It should be recognized that data on the value of car-
diac CTA in the diagnosis and treatment of IE are rela-
tively scarce, are derived from a few patients in highly 
experienced centers, and may not be generalizable to 
all centers managing patients with IE. ECG-gated cardi-
ac CTA also allows noninvasive assessment of coronary 
anatomy preoperatively in patients with surgical indica-
tion, in whom conventional invasive angiography could 
be contraindicated. The main relative limitations of CT 
are the radiation exposure and the risk of nephrotoxic-
ity associated with iodinated contrast injection. How-
ever, the potential advantages of CT to provide relevant 
diagnostic information overcome these limitations.
Because of its capability to image the entire body, CT 
also allows detection of extracardiac IE-related lesions. 
Peripheral lesions include those that can be found in 
the systemic circulation in the case of left-sided endo-
carditis, mainly intra-abdominal lesions of infective ori-
gin (splenic, renal, and hepatic infarctions or abscesses; 
mesenteric ischemia),18 central nervous system lesions, 
and other metastatic locations of the infection (spon-
dylodiscitis, septic arthritis, vascular mycotic aneurysm, 
etc),19 as well as those secondary to right-sided IE, 
mainly septic pulmonary emboli.
Value and Limitations of Nuclear Imaging 
Techniques
Abnormal activity around the site of prosthetic valve 
implantation detected by fluoro-18-fluorodeoxyglucose 
([18F]FDG) PET/CT or radiolabeled leukocytes SPECT/CT 
is considered a major criterion of the ESC 2015 IE crite-
ria. PET technology delivers high-resolution images by 
the use of biologically active compounds labeled with 
positron emitters. Image acquisition starts ≈45 to 60 
minutes after the injection of [18F]FDG, a radiolabeled 
glycogen analog that accumulates into cells such as 
activated inflammatory cells in infection and inflamma-
tion processes (activated leukocytes,20 monocyte mac-
rophages,21 and CD4+ T lymphocytes22). Uptake of the 
radiopharmaceutical is based on the high expression 
of glucose transporters, which actively incorporate the 
tracer into the cells. Metabolic activity is evaluated both 
qualitatively and quantitatively.23–26 To facilitate visualiza-
tion of presumed sites of valve infection, suppression of 
[18F]FDG uptake by normal myocardium in proper patient 
preparation is needed. There is a general consensus that 
a high-fat, low-carbohydrate diet for at least 2 meals 
with a fast of at least 4 hours is the minimum to obtain 
suppression of physiological myocardial glucose utiliza-
tion.25 Interpretation of [18F]FDG PET/CT images requires 
proper knowledge of the potential confounding normal 
and pathological conditions that may resemble the up-
take pattern typically observed in IE27 (ie, persistent host 
reaction against the biomaterial coating the sewing ring 
of the pulmonary valve and chronic tension or friction 
exerted on these anchor points28), as well as of the fac-
tors affecting the intensity of [18F]FDG uptake.29–31 If PET/
CT acquisition is combined with cardiac CT (PET/CTA), 
the metabolic findings provided by the [18F]FDG uptake 
distribution and intensity might be added to the ana-
tomic findings already described for cardiac CTA within 
a single imaging procedure.32 The advantages of com-
bining [18F]FDG PET/CTA include the identification of a 
larger number of anatomic lesions, clinical clarification 
in the context of other indeterminate studies,32,33 and 
its value in specific clinical situations such as in patients 
with aortic grafts and patients with congenital heart dis-
ease who have complex anatomy, because their surgical 
treatment often requires implantation of a large amount 
of prosthetic material.
The value of [18F]FDG PET/CT is limited in NVE, when 
cardiac infection is the target of this imaging technique, 
in which the sensitivity is too poor to recommend its 
routine use.34–36 However, in the case of NVE, the use 
of [18F]FDG PET/CT is useful for the detection of distant 
embolic events, a condition currently considered a mi-
nor criterion in the 2015 ESC guidelines (see below).
Radiolabeled white blood cell (WBC) SPECT/CT imag-
ing relies on the use of autologous radiolabeled leuko-
cytes (111In-oxine or 99mTc-hexamethylpropyleneamine ox-
ime) that accumulate in infection foci in a time-dependent 
fashion (late versus earlier images).37 However, the limited 
sensitivity of WBC SPECT/CT could affect its negative pre-
dictive value to exclude IE in all suspected cases. Disad-
vantages of WBC SPECT/CT are the requirement of blood 
handling for radiopharmaceutical preparation, the dura-
tion of the procedure, which is longer compared with PET/
CT, and a slightly lower spatial resolution and photon de-
tection efficiency compared with [18F]FDG PET/CT.
Notable advantages of PET/CT and WBC SPECT/CT 
are their ability to perform the extracardiac workup 
within a single imaging procedure and to reveal the 
concomitant presence of extracardiac infection sites as 
the consequence of both septic embolism and primary 
infective processes (with the exception of the brain lo-
cation because brain uptake is always high as a result of 
its specific metabolism).34,38,39 Detection of metastatic 
infection by [18F]FDG PET/CT led to a change in treat-
ment in up to 35% of patients.40 PET/CT has been dem-
onstrated to be able to reveal the source of infection, 
including cases in which the sustaining portal of entry 
was a neoplasia (colonic cancer).32
Which Technique for Which Patient?
What the Guidelines Say
The 2015 ESC guidelines added as major imaging criteria 
“pseudoaneurysm, intracardiac fistula, and valve perfora-
tion or aneurysm” detected by echocardiography, but also 
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and in the case of prosthetic valves, “abnormal activity 
around the site of implantation” detected by [18F]FDG PET/
CT.3 The use of CT was also recommended in the 2014 
American College of Cardiology Foundation/American 
Heart Association (Class IIa, Level of Evidence B) guide-
lines to evaluate morphology/anatomy in the setting of 
suspected paravalvular infections when the anatomy can-
not be clearly delineated by echocardiography.41 The 2015 
American Heart Association scientific statement18 does 
not assign recommendation class or level of evidence for 
the use of both CTA and nuclear imaging but highlights 
that the use of MMI in IE may increase in the future.
Figures 1 and 2 provide clinical cases that underline 
the value of a comprehensive MMI evaluation in a pa-
tient with NVE and PVE, respectively.
Proposed Clinical Algorithms for NVE and PVE
The following algorithm is for NVE (Figure 3):
• Echocardiography must be performed in all 
patients with suspected IE as the first imaging 
test. Both echocardiography modalities, TTE and 
TEE, should be performed in nearly all cases to 
evaluate anatomic involvement and hemodynamic 
consequences.
• When TTE is negative and the IE suspicion remains 
high, TEE is indicated to confirm or rule out the 
diagnosis because of its higher sensitivity to detect 
vegetations (90%–100% for TEE versus 40%–
63% for TTE).42
• Beyond the diagnosis of IE, TEE should be per-
formed for a better assessment of perivalvular 
complications. TEE sensitivity is higher than that of 
TTE to detect abscesses (sensitivity, 87%; specific-
ity, 95%)8 and overall perivalvular complications.43
• If both TTE and TEE are negative or inconclusive, 
especially when performed early in the clinical 
course,44 they should be repeated within 1 week if 
high clinical probability of IE persists.
• Cardiac CTA might be used in the setting of sus-
pected paravalvular infection extension when the 
anatomy cannot be clearly delineated by echo-
cardiography because of suboptimal acoustic 
Figure 1. Mitral native valve infective endocarditis (NVE) complicated by perivalvular abscess and splenic embolism.  
A 78-year-old patient was admitted with fever and had blood cultures positive for Streptococcus agalactiae. Echocardiography found several vegetations 
on the mitral valve (A and B, arrows). The diagnosis of mitral NVE was established, and antibiotic treatment was started. Because of respiratory conditions, 
transesophageal echocardiography was performed 7 days later and found vegetation growth (from 7–20 mm), causing significant mitral obstruction (C). 
Severe calcification of the mitral annulus did not allow perivalvular complications assessment. The patient had persistent fever and control blood cultures 
remained positive. Because of suspected perivalvular complications and uncontrolled infection, a cardiac computed tomography (CT) was performed and 
showed mitral valve leaflet thickening with multiple vegetations, severe calcification of the mitral annulus with destruction of its posterior aspect, and a 
poorly delimited soft-tissue lesion in the inferior atrioventricular sulcus consistent with a perivalvular abscess (D, arrowheads), causing compression of the 
coronary sinus (E, arrowheads). Hypodense intramyocardial areas suggested infectious involvement of the ventricular wall (E, arrow). Upper abdominal im-
ages also showed a small splenic embolism (F, arrow). On the basis of the cardiac CT angiography (CTA) findings, the multidisciplinary infective endocarditis 
team agreed on the indication to surgery followed by antibiotic treatment. All image findings were confirmed. Valve RNA polymerase chain reaction was 
positive for S agalactiae. The patient completed a total of 8 weeks of antibiotics and is doing well. This case illustrates the value of a comprehensive multi-
modality imaging evaluation in a patient with NVE when cardiac CTA completed a suboptimal echocardiographic study, adding information on perivalvular 
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Figure 2. Aortic prosthetic valve infective endocarditis (PVE) complicated by periprosthesis abscess and spondylodiscitis. 
A 73-year-old patient with an aortic bioprosthesis implanted 5 months previously was admitted for an ischemic stroke and suspected prosthetic thrombosis. A 
few days after admission, he developed fever and back pain. Blood cultures were positive for Staphylococcus epidermidis. Transesophageal echocardiography 
(TEE) showed an 8-mm aortic vegetation (A, arrowhead) and a possible periprosthetic thickening (A, arrows). In this case of S epidermidis early PVE, TEE revealed 
an inconclusive finding of periprosthetic thickening. Fluoro-18-fluorodeoxyglucose positron emission tomography ([18F]FDG PET)/computed tomographic angiog-
raphy (CTA) was then performed to clarify the periprosthetic extension of the infection and to rule out the presence of systemic embolism, which were suspected 
on the basis of the clinical history (ischemic stroke and occurrence of back pain). Images (B and D, arrowheads) show an intense hypermetabolic (maximum 
standard uptake value, 13.4), poorly delimited 11-mm-thick soft-tissue lesion around the valve (B, C, and E, arrows) consistent with a periprosthetic abscess 
and a small pseudoaneurysm from the left ventricular outflow tract (E, white arrow). The whole-body [18F]FDG PET/CT also showed an L1-L2 spondylodiskitis (F, 
arrows). On the basis of the imaging findings, the multidisciplinary endocarditis team opted for surgery followed by antibiotics. This case illustrates the value of 
a multimodality imaging evaluation in a patient with PVE in whom [18F]FDG PET/CTA identified both a periprosthetic involvement undiagnosed by echocardiogra-
phy and the presence of infective endocarditis–related peripheral lesions, reinforcing the surgical indication. In this case, the choice of performing PET/CTA rather 
than cardiac CTA was based on the higher sensitivity of PET/CTA in the setting of PVE for both valvular involvement and extracardiac workup. Surgery confirmed 
all image findings, and the prosthetic valve culture was positive for the same microorganism. The patient was treated with antibiotics for a total of 8 weeks, and 
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windows or artifacts caused by, for example, severe 
calcifications. In addition, cardiac CTA allows pre-
operative risk stratification, accurately assessing 
the IE-related perivalvular lesions for a better pro-
cedure planning,17,45 and allows the evaluation of 
coronary artery disease.
• [18F]FDG PET/CTA, if available, can be used as 
alternative or complementary technique to cardiac 
CTA. Although there is no consistent scientific evi-
dence, the addition of metabolic activity informa-
tion could increase diagnostic accuracy.
For PVE (Figure 4), the following algorithm apples:
• TTE and TEE must be performed systematically in 
patients with PVE.3,41,46 The sensitivity of TTE and 
TEE in PVE is 50% and 92%, respectively.
• If TTE and TEE are negative, especially when per-
formed early in the clinical course,44 they might be 
repeated within 1 week if high clinical probability 
of IE persists.
• Patients with possible or even ruled-out IE by 
Duke criteria but with high clinical suspicion 
should be sent to a reference center, where the 
most appropriate technique to be performed can 
be chosen (CTA, PET/CTA, WBC imaging) to con-
firm or rule out IE.
SCENARIO 2: RIGHT-SIDED IE
Value and Limitations of Echocardiography
Right-sided heart involvement is usually easy to de-
tect with TTE because of the anterior location of this 
valve and usual large vegetations,47,48 although the 
right side of the heart has many echocardiographical-
ly anatomic facets that may be difficult to distinguish 
from vegetations.49 Eustachian and pulmonary valves 
should always be assessed. TEE is more sensitive in 
the detection of pulmonary vegetations50 and associ-
ated left-sided involvement and in the evaluation of 
central intravenous catheters and devices, prosthetic 
valve, foreign bodies, unusual locations of right-sided 
IE, and complications (eg, perivalvular abscesses) after 
failure to respond to therapy.51
TTE and TEE have complementary roles and are rec-
ommended in cases of suspected CIED infections. TTE 
defines better the presence of prognostic features such 
Figure 3. Diagnosis algorithm for suspected native valve infective endocarditis (IE). 
CT indicates computed tomography; CTA, computed tomographic angiography; ESC, European Society of Cardiology; MRI, magnetic resonance imaging; PET, 
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as pericardial effusion, ventricular dysfunction, and 
pulmonary arterial pressure. TEE is superior to TTE in 
the detection and sizing of vegetations52 and allows 
visualization of lead vegetations in the right atrium–
superior vena cava area and in other regions less well 
visualized by TTE. Diagnosis of CIED infection is fre-
quently difficult by both TTE and TEE, particularly the 
differentiation between noninfected thrombus and 
infected vegetation. In addition, a negative result can-
not exclude infection of the extracardiac portion of the 
device, the assessment of which is beyond the reach of 
echocardiography.
In patients with CIED infections, a TTE before hospital 
discharge is also recommended to detect the presence 
of retained segments of pacemaker leads and to assess 
tricuspid valve function, right ventricular function, and 
pulmonary hypertension. In addition, a TEE after percu-
taneous lead extraction should be considered to detect 
residual infected material and potential tricuspid valve 
complications.
Intracardiac echocardiography has been found to be 
feasible and effective in patients with a cardiac device 
with high sensitivity for detecting vegetations in cardiac 
devices.53
Value and Limitations of Other Imaging 
Techniques
CTA, [18F]FDG PET/CTA, and WBC SPECT/CT might be 
used in all cases when right-sided IE (particularly PVE) or 
CIED involvement is suspected. Contrast-enhanced CT 
may reveal pulmonary emboli, infarcts, and abscesses. 
Ventilation-perfusion scintigraphy may be an alterna-
tive to CT to screen for septic pulmonary embolism.54 
[18F]FDG PET/CTA and WBC SPECT/CT have largely re-
placed ventilation-perfusion scintigraphy, allowing the 
contemporary assessment of right- and left-sided valves 
and sites of distant embolisms and portal of entry.1
[18F]FDG PET/CTA is useful in patients with evidence 
of pocket infection (local signs of inflammation at the 
generator pocket, including erythema, warmth, fluctu-
ance, wound dehiscence, erosion, tenderness, or puru-
lent drainage3) and negative microbiological and echo-
cardiographic examination and in patients with positive 
Figure 4.  Diagnosis algorithm for suspected prosthetic valve infective endocarditis (IE).  
BC indicates blood culture; CT computed tomography; CTA, computed tomographic angiography; ESC, European Society of Cardiology; MRI, magnetic resonance 
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blood cultures but negative echocardiographic exami-
nation. [18F]FDG PET/CTA provides added diagnostic 
value to the Duke criteria, particularly in the subset of 
patients with possible CIED infection,55–60 and it has the 
capability to explore the whole device. Its diagnostic 
accuracy is very high in pocket/generator infection, in 
which mild inflammatory changes after device implan-
tation usually do not extend beyond 6 weeks and are 
easily differentiated from infection after this period. 
Studies have shown almost 100% accuracy for diag-
nosing infection of the generator pocket and the extra-
cardiac portion of the lead55–57,60 (sensitivity, specificity, 
and accuracy for the diagnosis of pocket infection were 
93%, 98%, and 98%, respectively). In cases of lead-
related IE, [18F]FDG PET/CTA is very specific when tracer 
uptake is visualized. However, its sensitivity is low, and 
a negative result does not completely exclude the pres-
ence of small vegetations with low metabolic activity.57
Which Technique for Which Patient?
What the Guidelines Say
TTE should be performed in all patients with suspected 
right-sided heart endocarditis, complemented by TEE in 
case of inconclusive TTE results and in the presence of 
an intracardiac prosthesis or device, even if only pocket 
infection is suspected.3 Radiolabeled leucocyte scintigra-
phy and [18F]FDG PET/CTA scanning may be considered 
additive tools in patients with suspected CIED infection, 
positive blood cultures, and negative echocardiography.
Figures  5 and 6 provide clinical cases that under-
line the value of a comprehensive MMI evaluation in 
a patient with right-sided NVE and CIED infection, re-
spectively.
Proposed Clinical Algorithm in CDRIE 
Figure  7 provides an algorithm for suspected cardiac 
device-related IE.
• Blood cultures and echocardiographic examina-
tions (TTE and TEE) should be performed in all 
patients with suspected CIED infection, even if 
only pocket infection is suspected.
• When echocardiography and blood cultures 
remain negative and in patients without evidence 
of pocket infection, no additional imaging is 
needed.
• However, a normal echocardiography does not rule 
out CIED infection. The Duke criteria are difficult to 
Figure 5. Tricuspid native valve infective endocarditis (NVE) complicated by pulmonary embolism.  
A 29-year-old man, an intravenous drug abuser, was admitted with fever and blood cultures positive for Staphylococcus aureus. Transesophageal echocardiogra-
phy (TTE) showed a 14×11–mm tricuspid vegetation (A, arrows). This case of S aureus tricuspid NVE was promptly diagnosed by TTE. Despite adequate antibiotic 
treatment (cloxaciline), the patient developed septic shock, right-sided heart failure, and respiratory insufficiency with severe hypoxemia and massive hemoptysis. 
A repeat TEE revealed vegetation growth (19×15 mm; B), right ventricular dilatation with severe tricuspid insufficiency (C), and severe pulmonary hypertension. A 
thoracic non-ECG-gated computed tomography (CT) was performed and showed a large tricuspid vegetation (D, arrows); multiple bilateral pulmonary nodules, 
some of them cavitated (E, arrow); congestive signs; and pulmonary emboli (F, arrow). The multidisciplinary endocarditis team chose a conservative approach in 
this patient. This case illustrates the role of a multimodality imaging evaluation in a patient with right-sided NVE in whom CT was useful for an adequate assess-
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apply in these patients because of lower sensitivity,61 
even when the modified Duke criteria are used.
• Because of the frequently difficult diagnosis of the 
disease and some limitations of echocardiography, 
MMI has been successfully applied in patients with 
CIED infections.
• [18F]FDG PET/CTA is useful in patients with evi-
dence of pocket infection and negative microbio-
logical and echocardiographic examination and in 
patients with positive blood cultures but negative 
echocardiographic examination.
• Its diagnostic accuracy is very high in pocket/gen-
erator infection but is lower when the infection is 
limited to the lead of the device.
• When [18F]FDG PET/CTA is not available, chest CTA 
may be performed to detect pulmonary embo-
lism, infarct, or abscess. A venous-phase CT can 
be performed to assess permeability of venous 
access when a new device has to be implanted.
CONCLUSIONS
MMI is of utmost value in the diagnosis and manage-
ment of IE. Echocardiography, cardiac and extracardiac 
CT, cerebral magnetic resonance imaging, and nuclear 
techniques have been shown to be useful in suspected 
and definite IE, but their indications may depend on 
the type of endocarditis (prosthetic versus native versus 
cardiac device related), the clinical status of the patient, 
and the possible limitations in using contrast agents. 
Although promising, this new approach needs further 
validation in prospective cohorts to define the optimal 
indications and timing of each of these techniques.
The next challenges are listed below:
– The determination of the MMI prognostic value;
– The demonstration that MMI can help in the 
choice of the best therapeutic option;
– The cost-efficiency of using MMI in IE, especially 
what is the least costly with highest efficiency in 
each individual patient; and
Figure 6. Cardiac implantable electronic device (CIED)–related infective endocarditis. 
A 66-year-old patient had an implantable cardioverter defibrillator (ICD) with a generator placed in the left side of the chest and leads in the right atrium and 
ventricle. During a generator replacement, a lead was damaged, and a complete contralateral right-sided chest device had to be implanted. As a result of left sub-
clavian vein occlusion, the old left leads could not be removed and were entirely abandoned. He was evaluated for pain, swelling, and erythema of the left-sided 
old pocket. Blood cultures were negative, but local purulent material culture was positive for Staphylococcus epidermidis. Local infection at the site of the previous 
ICD was diagnosed. Echocardiography was performed (A) and was negative. A fluoro-18-fluorodeoxyglucose positron emission tomography ([18F]FDG PET)/com-
puted tomography (CT) was performed to assess the involvement of the abandoned left-sided leads and the status of the new CIED. A [18F]FDG PET/CT showed 
focal [18F]FDG uptake on the abandoned leads at the old left-sided pocket (B and D, arrow) and on their intravascular segment (E and F, arrows). Old pocket–
associated anatomic findings were fat stranding and skin retraction (C, arrowheads). There were no signs of infection of the new ICD generator pocket (D, open 
arrow), but focal [18F]FDG uptake was visualized on the intravascular segment of the new device leads (G, arrow). On the basis of the results of PET/CT, extraction 
of both the old and new ICD systems was performed followed by treatment with daptomycin. Device cultures confirmed S epidermidis infection. A new right-sided 
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– The assessment of the feasibility of using this MMI 
strategy in different countries with different access 
to imaging techniques.
The decision to use MMI should ideally be made in 
reference centers complemented by the use of an en-
docarditis team. The MMI approach also requires car-
diac imaging experts to be involved in the evaluation 
of patients with suspected or proven IE, ideally as an 
imaging team within the endocarditis team.
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